Anthem Biosciences share price Rising Today: Stock Gains 2.27% on 20 July 2026, Here Is Why

The Anthem Biosciences share price is rising sharply today, with the stock trading up 2.27 percent at Rs 794.65 on Monday, 20 July 2026, placing it among the day’s most watched movers. Anthem Biosciences, a contract research, development and manufacturing company, has seen active trading through the session as the move drew attention across market screens.

This article breaks down the price action, the reasons driving the Anthem Biosciences share price higher, the sector backdrop, and the levels traders and investors should now track.

Click Here – Get Free Investment Predictions

How the Anthem Biosciences share price Is Trading Today

The stock opened at Rs 777.00 against the previous close of Rs 777.00, touched an intraday high of Rs 807.25 and a low of Rs 777.00, and was last quoting at Rs 794.65. The intraday range shows buyers dominating the session, and the Anthem Biosciences share price is holding near the upper end of the day’s band as trading progresses.

Reading the tape alongside the price helps: a stock closing its session near the high with expanding volumes typically signals accumulation rather than a squeeze, and follow-through buying often appears in the subsequent session. The day’s numbers for the Anthem Biosciences share price are summarised below.

Metric	Value
Last Traded Price	Rs 794.65
Change	+2.27%
Open	Rs 777.00
Intraday High	Rs 807.25
Intraday Low	Rs 777.00
Previous Close	Rs 777.00

Confused About What This Move Means for Your Portfolio? Ask a SEBI-Registered Investment Advisor

Why Is the Anthem Biosciences share price Rising Today

The Anthem Biosciences share price is gaining 2.27 percent to Rs 794.65 as the CRDMO theme powers ahead within Monday’s healthcare rally, alongside Neuland Laboratories and Onesource Specialty Pharma. The integrated discovery-to-manufacturing platform, spanning small molecules, biologics and specialty ingredients, is among the purest listed plays on global pharma outsourcing to India, and the stock’s move toward Rs 807 intraday on strong volumes extends its well-received listed run.

Momentum and positioning are adding fuel to the move. Once a stock breaks out with volume in a selective market, short-term traders pile in and intraday supply thins, extending the advance, which is visible in the width of today’s trading range in the Anthem Biosciences share price.

What This Move Means for Investors

The client funnel from discovery projects converting into commercial manufacturing is the compounding engine; quarterly disclosures on new client additions and capacity utilisation are the metrics that will keep validating the premium.

For existing shareholders, the practical question is whether the move changes the investment thesis. A single session of gains rewards patience but should not by itself trigger chasing; the durable signal comes from how the Anthem Biosciences share price behaves over the next few sessions and what the next set of disclosures confirms.

Portfolio construction principles apply regardless of direction: concentration in any single mover magnifies both outcomes, and rebalancing rules exist precisely for days like this. Whether the Anthem Biosciences share price extends or reverses, position sizes aligned to conviction and risk capacity are what keep single-stock volatility from becoming a portfolio problem.

Sector and Market Context

Pharmaceutical and healthcare stocks are among Monday’s strongest pockets, with Torrent Pharmaceuticals, Mankind Pharma, Cipla, Emcure Pharmaceuticals and Neuland Laboratories all rising 3 percent or more alongside diagnostics names. The sector is drawing defensive flows on a day banking heavyweights are falling after Q1 results, and a weaker rupee at 96.41 per dollar adds an export earnings tailwind for dollar-billing drugmakers. Rotational moves of this breadth typically persist for several sessions once underway.

Monday’s tape rewards selectivity, and that is the environment this rally is unfolding in. The benchmarks are soft on post-results banking pressure, crude near 90 dollars keeps global sentiment guarded, and the rupee has weakened to 96.41 per dollar. Against those crosswinds, a stock rising with volume is displaying relative strength, which momentum investors track as a leading indicator of institutional accumulation. The behaviour of such leaders once the index stabilises is typically the tell for whether a broader rotation is underway.

Anthem Biosciences share price: Key Levels to Watch

On the charts, the day’s range itself provides the map. The intraday high of Rs 807.25 is the immediate resistance; a close above it would extend the breakout, while the Rs 777.00 opening level and the previous close of Rs 777.00 form the support zone on any pullback. Volume behaviour at these levels will show whether the move in the Anthem Biosciences share price is being accumulated or faded.

Beyond the day’s map, position management matters more than prediction in moves like this. Traders riding the momentum typically trail stops below successive support levels rather than exiting at targets, letting the trend decide the exit, while longer-term investors can use the volatility to study whether the Anthem Biosciences share price is approaching levels that match their own valuation work.

Download the Univest iOS App or Univest Android App to track the Anthem Biosciences share price live with research-backed insights and portfolio analytics.

Reading the Anthem Biosciences share price Move in the Wider Session

It also helps to remember how results-season tapes behave. Monday follows the quarter’s heaviest earnings weekend, so the market is processing an unusual density of information, and price discovery in individual counters can overshoot in both directions before settling. Historically, moves that survive the second and third sessions with supportive volumes prove durable, while those built purely on intraday churn fade. That framework is the practical way to track this stock through the week. Delivery percentages, bulk deal disclosures and any changes in derivative positioning where available add further confirmation layers for those who want to track the move with more precision than price alone provides.

Conclusion

The Anthem Biosciences share price is rising today, up 2.27 percent at Rs 794.65, driven by the mix of company-specific interest and sector currents described above. The intraday high of Rs 807.25 is now the level to watch, and the coming sessions will reveal whether the move extends or consolidates. Investors should align any action with their goals and risk profile, ideally with guidance from a SEBI-registered investment advisor.

Frequently Asked Questions FAQs

Why is the Anthem Biosciences share price rising today?

Ans. The Anthem Biosciences share price is up 2.27 percent at Rs 794.65 on 20 July 2026. The Anthem Biosciences share price is gaining 2.27 percent to Rs 794.65 as the CRDMO theme powers ahead within Monday’s healthcare rally, alongside Neuland Laboratories and Onesource Specialty Pharma. The integrated discovery-to-manufacturing platform, spanning small molecules, biologics and specialty ingredients, is among the purest listed plays on global pharma outsourcing to India, and the stock’s move toward Rs 807 intraday on strong volumes extends its well-received listed run.

What is the Anthem Biosciences share price today?

Ans. As of Monday, 20 July 2026, the Anthem Biosciences share price is trading at Rs 794.65, up 2.27 percent from the previous close of Rs 777.00, with an intraday high of Rs 807.25 and a low of Rs 777.00.

What are the key levels to watch for the Anthem Biosciences share price?

Ans. The intraday high of Rs 807.25 is the immediate resistance, while the opening level of Rs 777.00 and previous close of Rs 777.00 act as support.

What does Anthem Biosciences do?

Ans. Anthem Biosciences is a contract research, development and manufacturing company listed on the Indian stock exchanges. The stock is among the day’s top gainers on 20 July 2026.

Is the move in the Anthem Biosciences share price linked to the broader market?

Ans. Partly. The broader indices are lower after the weekend’s bank results, which makes the stock’s gain a sign of relative strength backed by sector and stock-specific factors.

Should I buy Anthem Biosciences shares after this move?

Ans. A single-day move is not an investment thesis by itself. Evaluate the company’s fundamentals, upcoming disclosures and valuations against your goals and risk profile, and consult a SEBI-registered investment advisor before investing.

How should traders approach the Anthem Biosciences share price now?

Ans. Traders typically use the day’s range as the reference: longs above the breakout with stops below the opening level, while respecting the elevated volatility of a results-season session.